Towards Accurate and Interpretive Disease Diagnosis for Aging Adults Through Deep Learning Framework
DOI:
https://doi.org/10.54097/4591rt11Keywords:
Deep Learning, Machine Learning, Transformer, Disease Diagnosis, Human Gut MicrobiomeAbstract
Population aging has become a serious problem all around the world. The world's population is aging faster than ever before. What’s worse is that as the population ages, a serious problem arises: as the number of elderly people increases, medical resources begin to become scarce. For example, during the COVID-19 pandemic, many elderly people died due to lack of treatment and other medical resources such as masks. Similar to the COVID-19, some diseases are believed to be closely related to age and lead to higher mortality rates among the elderly. It is becoming more important to establish an efficient and accurate diagnostic system for such diseases. In this way, the impact of population aging on society can also be further alleviated. The rapid development of artificial intelligence technology can bring a turning point to this problem. Deep learning has become one of the most current topics in the field of artificial intelligence. With the swelling data of the Internet, deep learning showed emerging power to solve problems from various subjects that traditional machine learning methods could not handle well. Disease diagnosis is exactly one of them. In this research, We are aimed to build an accurate and interpretive disease diagnosis model leveraging the deep learning framework, specifically the Transformer, to diagnose the physical conditions of the elderly and reveal the relationship between specific microbiomes and disease. The key to the problem lies in what the classification model uses as features. Human gut microbiome has been proved to involve in a variety of chemical and biological processes in the human body and have complex connection with our health including specific diseases. In fact, sampling gut microbiome from patients to do disease diagnosis has been expected to be a more efficient and non-invasive method comparing to existed method such as blood test. Furthermore, the rapid development of gene sequencing technology also provides strong hardware support for this idea such as High-throughput sequencing. The core idea of this study is to use the relative abundance of human intestinal microorganisms as features to train a high-precision classification model for specific disease diagnosis. We evaluated five algorithms on six different and independent datasets with three age-related diseases. The results showed that Transformer could show the best performance in most of the cases, although it demands more computing resources to train. Furthermore, we managed to improve the generalization ability with the MK-MMD method. Finally, we did biomarker discovery to all the models with decent performance by SHAP and student t-test.
Downloads
References
[1] Bradley, David, and Willa Hsueh. “Type 2 Diabetes in the Elderly: Challenges in a Unique Patient Population.” Journal of geriatric medicine and gerontology Vol. 2,2 (2016): 14.
[2] Bethel, M Angelyn et al. “Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.” Archives of internal medicine Vol. 167,9 (2007): 921-7.
[3] Zhou, Zheng et al. “Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.” Frontiers in cellular and infection microbiology Vol. 12 (2022) 834485.
[4] “2023 Alzheimer's disease facts and figures.” Alzheimer's & dementia : the journal of the Alzheimer's Association Vol. 19,4 (2023): 1598-1695.
[5] Fung, Thomas C et al. “Interactions between the microbiota, immune and nervous systems in health and disease.” Nature neuroscience Vol. 20,2 (2017): 145-155.
[6] Ferreiro, Aura L et al. “Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.” Science translational medicine Vol. 15,700 (2023): eabo2984.
[7] Cho, Ilseung, and Martin J Blaser. “The human microbiome: at the interface of health and disease.” Nature reviews. Genetics Vol. 13,4 260-70. 13 Mar. 2012.
[8] Oh, Min, and Liqing Zhang. “DeepMicro: deep representation learning for disease prediction based on microbiome data.” Scientific reports Vol. 10,1 6026. 7 Apr. 2020.
[9] Herui Liao, Jiayu Shang, Yanni Sun, GDmicro: classifying host disease status with GCN and deep adaptation network based on the human gut microbiome data, Bioinformatics, Vol. 39,12 Dec. 2023.
[10] Reiman, Derek et al. “PopPhy-CNN: A Phylogenetic Tree Embedded Architecture for Convolutional Neural Networks to Predict Host Phenotype From Metagenomic Data.” IEEE journal of biomedical and health informatics Vol. 24,10 (2020): 2993-3001.
[11] Pasolli, Edoardo et al. “Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights.” PLoS computational biology Vol. 12,7 e1004977. 11 Jul. 2016.
[12] Ashish Vaswani, Noam Shazeer, Niki Parmar, Jakob Uszkoreit, Llion Jones, Aidan N. Gomez, Łukasz Kaiser, and Illia Polosukhin. 2017. Attention is all you need. In Proceedings of the 31st International Conference on Neural Information Processing Systems (NIPS'17). Curran Associates Inc., Red Hook, NY, USA, 6000–6010.
[13] Li, Qian et al. “Implication of the gut microbiome composition of type 2 diabetic patients from northern China.” Scientific reports Vol. 10,1 5450. 25 Mar. 2020.
[14] Ahmad, Aftab et al. “Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals.” PloS one Vol. 14,12 e0226372. 31 Dec. 2019.
[15] Vogt, Nicholas M et al. “Gut microbiome alterations in Alzheimer's disease.” Scientific reports Vol. 7,1 13537. 19 Oct. 2017.
[16] Troci, Alba et al. “Disease- and stage-specific alterations of the oral and fecal microbiota in Alzheimer's disease.” PNAS nexus Vol. 3,1 pgad427. 11 Dec. 2023.
[17] Kang, Lin et al. “Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia.” Scientific reports Vol. 11,1 4628. 25 Feb. 2021.
[18] Zhou, Jing et al. “Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia.” Frontiers in pharmacology Vol. 14 1279448. 3 Nov. 2023.
[19] Breitwieser, F P et al. “KrakenUniq: confident and fast metagenomics classification using unique k-mer counts.” Genome biology Vol. 19,1 198. 16 Nov. 2018.
[20] Tom Fawcett, An introduction to ROC analysis, Pattern Recognition Letters, Vol. 27(2006) No.8, p.861-874.
[21] Gretton, A & Borgwardt, K. & Rasch, Malte & Schölkopf, Bernhard & Smola, AJ, A Kernel Two-Sample Test, The Journal of Machine Learning Research, Vol. 13(2012) p.723-773.
[22] Scott M. Lundberg and Su-In Lee: A unified approach to interpreting model predictions, International Conference on Neural Information Processing Systems (NY, USA, December, 2017) Vol. 1, p.4768–4777.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Computing and Electronic Information Management

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.








